GlassScriptPhysician profile
Vanna Manigault Jackson
NPI 1649228172
$1,725.48
in general payments reported to CMS, 2019-2025
17 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.22 · 2020: $19.19 · 2021: $276 · 2022: $312 · 2023: $430 · 2024: $421 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $489.34 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $250.69 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $195.56 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $120.91 | 2020-2025 | |
| Sanofi Pasteur INC. | $112.82 | 2022-2025 | |
| Cranial Technologies, INC | $108.15 | 2019-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $94.27 | 2021 | |
| Kaleo, INC. | $81.27 | 2019-2023 | Auvi-Q |
| Seqirus USA INC | $46.32 | 2024-2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $42.33 | 2021-2024 | Vaxneuvance, Gardasil, Gardasil 9 |
| Ars Pharmaceuticals Operations, INC. | $40.69 | 2025 | Neffy |
| Genzyme Corporation | $35.52 | 2021-2023 | |
| Tris Pharma INC | $34.49 | 2021 | |
| Shire North American Group INC | $24.23 | 2019 | |
| Alk-Abello, INC | $19.27 | 2025 | Neffy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $16.65 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanna Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.